Incidence of Guillain‐Barré syndrome during a nationwide oral poliovirus vaccine campaign
- 1 August 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (8) , 1034
- https://doi.org/10.1212/wnl.39.8.1034
Abstract
Concomitant with a nationwide oral poliovirus vaccine (OPV) campaign in Finland in 1985, an unexpected rise in the number of patients hospitalized with the Guillain-Barré syndrome (GBS) occurred. An analysis based on hospital records covering a population of 1.17 million and 6 years revealed a significantly increased incidence of GBS coinciding with the OPV campaign. We carefully examined 10 cases with onset of GBS within 10 weeks after immunization. Only 4 patients could recall recent symptomatic infection, and we found no specific agent in these cases. Our study suggests that live-attenuated polioviruses may, like other infectious viruses, sometimes trigger the GBS.This publication has 5 references indexed in Scilit:
- Guillain‐Barré syndromeNeurology, 1987
- OUTBREAK OF PARALYTIC POLIOMYELITIS IN FINLAND: WIDESPREAD CIRCULATION OF ANTIGENICALLY ALTERED POLIOVIRUS TYPE 3 IN A VACCINATED POPULATIONThe Lancet, 1986
- AN EPIDEMIOLOGIC AND CLINICAL EVALUATION OF GUILLAIN-BARRÉ SYNDROME REPORTED IN ASSOCIATION WITH THE ADMINISTRATION OF SWINE INFLUENZA VACCINESAmerican Journal of Epidemiology, 1984
- Guillain-Barré Syndrome and the 1978–1979 Influenza VaccineNew England Journal of Medicine, 1981
- GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771American Journal of Epidemiology, 1979